Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
© 2020 The Author(s)..
SMYD3 is frequently overexpressed in a wide variety of cancers. Indeed, its inactivation reduces tumor growth in preclinical in vivo animal models. However, extensive characterization in vitro failed to clarify SMYD3 function in cancer cells, although confirming its importance in carcinogenesis. Taking advantage of a SMYD3 mutant variant identified in a high-risk breast cancer family, here we show that SMYD3 phosphorylation by ATM enables the formation of a multiprotein complex including ATM, SMYD3, CHK2, and BRCA2, which is required for the final loading of RAD51 at DNA double-strand break sites and completion of homologous recombination (HR). Remarkably, SMYD3 pharmacological inhibition sensitizes HR-proficient cancer cells to PARP inhibitors, thereby extending the potential of the synthetic lethality approach in human tumors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
iScience - 23(2020), 10 vom: 23. Okt., Seite 101604 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sanese, Paola [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 19.11.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.isci.2020.101604 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317722514 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317722514 | ||
| 003 | DE-627 | ||
| 005 | 20231225163850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.isci.2020.101604 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317722514 | ||
| 035 | |a (NLM)33205017 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sanese, Paola |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.11.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2020 The Author(s). | ||
| 520 | |a SMYD3 is frequently overexpressed in a wide variety of cancers. Indeed, its inactivation reduces tumor growth in preclinical in vivo animal models. However, extensive characterization in vitro failed to clarify SMYD3 function in cancer cells, although confirming its importance in carcinogenesis. Taking advantage of a SMYD3 mutant variant identified in a high-risk breast cancer family, here we show that SMYD3 phosphorylation by ATM enables the formation of a multiprotein complex including ATM, SMYD3, CHK2, and BRCA2, which is required for the final loading of RAD51 at DNA double-strand break sites and completion of homologous recombination (HR). Remarkably, SMYD3 pharmacological inhibition sensitizes HR-proficient cancer cells to PARP inhibitors, thereby extending the potential of the synthetic lethality approach in human tumors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Cell Biology | |
| 650 | 4 | |a Molecular Biology | |
| 700 | 1 | |a Fasano, Candida |e verfasserin |4 aut | |
| 700 | 1 | |a Buscemi, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Bottino, Cinzia |e verfasserin |4 aut | |
| 700 | 1 | |a Corbetta, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Fabini, Edoardo |e verfasserin |4 aut | |
| 700 | 1 | |a Silvestri, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Valentini, Virginia |e verfasserin |4 aut | |
| 700 | 1 | |a Disciglio, Vittoria |e verfasserin |4 aut | |
| 700 | 1 | |a Forte, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Lepore Signorile, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a De Marco, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Bertora, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Grossi, Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Guven, Ummu |e verfasserin |4 aut | |
| 700 | 1 | |a Porta, Natale |e verfasserin |4 aut | |
| 700 | 1 | |a Di Maio, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Manoni, Elisabetta |e verfasserin |4 aut | |
| 700 | 1 | |a Giannelli, Gianluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Bartolini, Manuela |e verfasserin |4 aut | |
| 700 | 1 | |a Del Rio, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Caretti, Giuseppina |e verfasserin |4 aut | |
| 700 | 1 | |a Ottini, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Simone, Cristiano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t iScience |d 2018 |g 23(2020), 10 vom: 23. Okt., Seite 101604 |w (DE-627)NLM285332627 |x 2589-0042 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2020 |g number:10 |g day:23 |g month:10 |g pages:101604 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.isci.2020.101604 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2020 |e 10 |b 23 |c 10 |h 101604 | ||